Related Experiment Videos
Pertussis vaccine--an analysis of benefits, risks and costs
Insights
Routine childhood immunization against pertussis significantly reduces cases and deaths. Vaccination is cost-effective, but further research on vaccine safety and pertussis epidemiology is recommended.
Area of Science:
- Public Health
- Epidemiology
- Decision Analysis
Background:
- Pertussis (whooping cough) poses a significant public health threat to children.
- Assessing the benefits, risks, and costs of pertussis vaccination is crucial for public health policy.
Purpose of the Study:
- To estimate the benefits, risks, and costs of routine childhood immunization against pertussis using decision analysis.
- To provide evidence supporting the continuation of pertussis vaccination programs.
Main Methods:
- Decision analysis modeling was employed to evaluate the impact of a pertussis immunization program.
- Predictions were made regarding disease incidence, mortality, and associated encephalitis cases with and without vaccination.
Main Results:
- Without immunization, a 71-fold increase in pertussis cases and a fourfold increase in deaths per cohort are predicted.
- Vaccination is projected to reduce pertussis-related encephalitis and decrease overall pertussis costs by 61%.
- The analysis identified a need for more reliable data on vaccine complications and pertussis epidemiology.
Conclusions:
- Continuation of routine childhood pertussis vaccination is strongly supported by the analysis.
- Further research is needed on vaccine safety, pertussis epidemiology, and the development of improved vaccines.
Abstract:
Using decision analysis, we estimated the benefits, risks and costs of routine childhood immunization against pertussis. Without an immunization program, we predict that there would be a 71-fold increase in cases and an almost fourfold increase in deaths (2.0 to 7.6) per cohort of one million children. With a vaccination program, we predict 0.1 case of encephalitis associated with pertussis and five cases of post-vaccination encephalitis; without a program, there would be only 2.3 cases of encephalitis associated with pertussis. Community vaccination would reduce by 61 per cent the costs related to pertussis. Our analysis supports continuation of vaccination in routine childhood immunization programs, but suggests the need for more reliable data on complications from the vaccine, further study of the epidemiology of pertussis and development of a less toxic vaccine.